Joanne M. Donovan insider trades

Open-market stock purchases and sales by Joanne M. Donovan, CMO at Edgewise Therapeutics, Inc, from SEC Form 4 filings since Jun 30, 2015.

Recent trades

DateStockTradeValue
Aug 13, 2026EWTX Edgewise Therapeutics, IncSold$127K
Aug 12, 2026EWTX Edgewise Therapeutics, IncSold$124K
Aug 12, 2026EWTX Edgewise Therapeutics, IncSold$121K
Aug 12, 2026EWTX Edgewise Therapeutics, IncSold$4.6K
Aug 12, 2026EWTX Edgewise Therapeutics, IncSold$35.6K
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
May 5, 2026EWTX Edgewise Therapeutics, IncSold$1.9M
May 5, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
May 4, 2026EWTX Edgewise Therapeutics, IncSold$164K
Apr 1, 2026EWTX Edgewise Therapeutics, IncSold$926K
Apr 1, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
Mar 31, 2026EWTX Edgewise Therapeutics, IncSold$685K
Mar 31, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
Mar 27, 2026EWTX Edgewise Therapeutics, IncSold$298K
Mar 27, 2026EWTX Edgewise Therapeutics, IncSold$209K

Companies traded

  • EWTX Edgewise Therapeutics, Inc: 17 sales, last Aug 13, 2026
  • CATB Catabasis Pharmaceuticals Inc: other filings, last Feb 12, 2020

Get free alerts when Joanne M. Donovan files a new trade →